Table 2.
Allogeneic Hematopoietic Stem Cell-Transplanted Patients
| UPN# | Sex | Age at DSC treatment, years | Indication for DSC treatment | No. of DSC infusions | DSC treatment (weeks after HSCT) | FCXM test |
|---|---|---|---|---|---|---|
| 1011 | M | 8 | cGVHD | 2 | 398, 406 | Neg |
| 1265 | M | 18 | cGVHD | 2 | 195, 206 | Neg |
| 1462 | F | 65 | aGVHD | 2 | 16, 31 | Pos |
| 1468 | M | 58 | aGVHD | 1 | 15 | Neg |
| 1475 | F | 18 | cGVHD | 1 | 45 | Neg |
| 1504 | F | 53 | aGVHD | 3 | 6, 15, 19 | Neg |
| 1531 | M | 62 | aGVHD | 1 | 4 | Neg |
| 1563 | F | 8 | HC | 1 | 13 | Neg |
| 1583 | M | 58 | Toxicity, aGVHD | 2 | 1, 7 | Pos |
| 1587 | F | 41 | HC | 1 | 9 | Neg |
| 1588 | F | 24 | HC | 1 | 8 | Neg |
| 1589 | M | 48 | aGVHD | 3 | 44, 46, 47 | Neg |
| 1590 | F | 43 | HC | 1 | 5 | Neg |
| 1602 | M | 44 | HC | 1 | 6 | Neg |
| 1619 | F | 43 | aGVHD | 4 | 21, 22, 23, 39 | Neg |
| 1620 | M | 53 | aGVHD | 5 | 16, 17, 18, 23, 44 | Neg |
UPN, unique patient number; aGVHD, acute graft-versus-host disease; cGVHD, chronic graft-versus-host disease; HC, hemorrhagic cystitis.